Agios Pharma (AGIO) Misses Q2 EPS by 22c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Agios Pharma (AGIO) Misses Q2 EPS by 22c

Agios Pharma (AGIO) PT Raised to $83 at Oppenheimer on 2Q Report; 'Strong Clinical Update'

August 8, 2017 11:20 AM EDT

Oppenheimer raised its price target on Agios Pharma (NASDAQ: AGIO) to $83.00 (from $75.00) while maintaining a Outperform rating, following the company's second quarter earnings report.

Analyst Leah Cann notes the company delivered second quarter earnings per share results below expectations from higher research & development... More